Literature DB >> 26855484

Review and Recommendations for the Component Tests in the Liver Function Test Profile.

Tony Badrick1, Peter Turner2.   

Abstract

Pathology laboratories group some tests that they perform on their high throughput biochemistry analysers into profiles of tests that are associated with different organs (e.g. liver function tests-LFT). The components of these profiles are historic and often vary between different laboratories. This can lead to confusion and begs the question of what should be in a particular profile. In community medicine profiles may be used as screening tests but some of the components of the profiles may have low sensitivity and specificity and may produce both false positives and negatives. The LFT may include components which are poor liver function tests but are sensitive to fatty liver and hence elevations may cause unnecessary concern. Harmonisation of clinical chemistry reference intervals and units is occurring now so it is time to consider a similar process for components of a profile. A proposed list of analytes to be performed in the LFT profile is given.

Entities:  

Keywords:  Clinical chemistry profiles; Harmonisation; Liver function test

Year:  2015        PMID: 26855484      PMCID: PMC4731367          DOI: 10.1007/s12291-015-0493-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  29 in total

1.  Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues.

Authors:  R Rej
Journal:  Clin Chem       Date:  1978-11       Impact factor: 8.327

Review 2.  The de ritis ratio: the test of time.

Authors:  Mona Botros; Kenneth A Sikaris
Journal:  Clin Biochem Rev       Date:  2013-11

Review 3.  Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?

Authors:  H Mardini; C Record
Journal:  Ann Clin Biochem       Date:  2005-11       Impact factor: 2.057

4.  Alcohol consumption guidelines: relative safety vs absolute risks and benefits.

Authors:  R Jackson; R Beaglehole
Journal:  Lancet       Date:  1995-09-16       Impact factor: 79.321

5.  Body weight, alcohol consumption and liver enzyme activity--a 4-year follow-up study.

Authors:  D H Lee; M H Ha; D C Christiani
Journal:  Int J Epidemiol       Date:  2001-08       Impact factor: 7.196

6.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

7.  The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

Authors:  George N Ioannou; Edward J Boyko; Sum P Lee
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

8.  Silent non-alcoholic fatty liver disease-a clinical-histological study.

Authors:  Paolo Sorrentino; Giovanni Tarantino; Paolo Conca; Alessandro Perrella; Maria Luigi Terracciano; Raffaella Vecchione; Giovanna Gargiulo; Nicola Gennarelli; Roberto Lobello
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

9.  Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study.

Authors:  R Loomba; R Bettencourt; E Barrett-Connor
Journal:  Aliment Pharmacol Ther       Date:  2009-09-08       Impact factor: 8.171

10.  The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI).

Authors:  David J McLernon; John F Dillon; Frank M Sullivan; Paul Roderick; William M Rosenberg; Stephen D Ryder; Peter T Donnan
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more
  2 in total

1.  Assessment of function, histopathological changes, and oxidative stress in liver tissue due to ionizing and non-ionizing radiations.

Authors:  Sajad Borzoueisileh; Ali Shabestani Monfared; Hossein Ghorbani; S M J Mortazavi; Ebrahim Zabihi; Mehdi Pouramir; Amir Hossein Doustimotlagh; Mohsen Shafiee; Fatemeh Niksirat
Journal:  Caspian J Intern Med       Date:  2020-05

2.  Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data.

Authors:  Theresa Hydes; Michael Moore; Beth Stuart; Miranda Kim; Fangzhong Su; Colin Newell; David Cable; Alan Hales; Nick Sheron
Journal:  BMJ Open       Date:  2021-02-11       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.